Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Clinical trial NCT04088188 · TERMINATED
Trial details
- NCT number
- NCT04088188
- Sponsor
- Academic and Community Cancer Research United
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2023-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.